NCT02750917View on ClinicalTrials.gov

Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2015

Conditions
Postoperative Pain
Interventions
DRUG

Lornoxicam

At the end of surgery patients in group LORNOXICAM received one pill of 8 mg lornoxicam every 12 hours in the surgery day and first postoperative day.

DRUG

Etoricoxib

At the end of surgery patients in the ETORICOXIB group received one pill of 120 mg etoricoxib at the end of surgery and a second one after 24 hours. This group also received placebo pills at 12 h, between the active pills.

All Listed Sponsors
lead

Foisor Orthopedics Clinical Hospital

OTHER

NCT02750917 - Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter